Chen L - Search Results

1

Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome.

Du M, Liu C, Chen L, Li Z, Zhang S, Meng R. Du M, et al. Among authors: chen l. Clin Respir J. 2024 Dec;18(12):e70041. doi: 10.1111/crj.70041. Clin Respir J. 2024. PMID: 39681089 Free PMC article. Review.

2

Small cell conversion complicated with hypertrophic pulmonary osteoarthropathy after targeted therapy for advanced EGFR-mutated lung adenocarcinoma: A case report.

Zhang S, Chen L, Zhu K, Meng R. Zhang S, et al. Among authors: chen l. Indian J Pathol Microbiol. 2024 Jan-Mar;67(1):217-222. doi: 10.4103/ijpm.ijpm_280_22. Indian J Pathol Microbiol. 2024. PMID: 38358227 Free article.

3

Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report.

Zhang S, Xiao Y, Chen L, Li Z, Zong Y, Zhu K, Meng R. Zhang S, et al. Among authors: chen l. Open Life Sci. 2022 Jun 15;17(1):577-585. doi: 10.1515/biol-2022-0062. eCollection 2022. Open Life Sci. 2022. PMID: 35800072 Free PMC article.

4

Research progress of tumor-derived extracellular vesicles in the treatment of malignant pleural effusion.

Zhang S, Chen L, Zong Y, Li Q, Zhu K, Li Z, Meng R. Zhang S, et al. Among authors: chen l. Cancer Med. 2023 Jan;12(2):983-994. doi: 10.1002/cam4.5005. Epub 2022 Jul 21. Cancer Med. 2023. PMID: 35861052 Free PMC article. Review.

5

Effect of Stereotactic Body Radiation Therapy on Diverse Organ Lesions in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Zhu KK, Wei JL, Xu YH, Li J, Rao XR, Xu YZ, Xing BY, Zhang SJ, Chen LC, Dong XR, Zhang S, Li ZY, Liu CW, Meng R, Wu G. Zhu KK, et al. Curr Med Sci. 2023 Apr;43(2):344-359. doi: 10.1007/s11596-023-2702-0. Epub 2023 Mar 31. Curr Med Sci. 2023. PMID: 37002471

6

An unusual ectopic thymoma clonal evolution analysis: A case report.

Zhang S, Wu L, Li Z, Li Q, Zong Y, Zhu K, Chen L, Qin H, Meng R. Zhang S, et al. Among authors: chen l. Open Life Sci. 2023 May 18;18(1):20220600. doi: 10.1515/biol-2022-0600. eCollection 2023. Open Life Sci. 2023. PMID: 37215501 Free PMC article.

7

The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics.

Zhang S, Zong Y, Chen L, Li Q, Li Z, Meng R. Zhang S, et al. Among authors: chen l. Discov Oncol. 2023 Jun 16;14(1):103. doi: 10.1007/s12672-023-00729-9. Discov Oncol. 2023. PMID: 37326784 Free PMC article. Review.

8

Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases.

Luo Q, Chen L, Li Z, Cheng L, Zhang S, Zong Y, Li Q, Suda K, Santarpia M, Dalia S, Meng R. Luo Q, et al. Among authors: chen l. Transl Lung Cancer Res. 2023 Nov 30;12(11):2330-2341. doi: 10.21037/tlcr-23-542. Epub 2023 Nov 20. Transl Lung Cancer Res. 2023. PMID: 38090524 Free PMC article.

9

Protein kinase CK2: An emerging regulator of cellular metabolism.

Deng H, Rao X, Zhang S, Chen L, Zong Y, Zhou R, Meng R, Dong X, Wu G, Li Q. Deng H, et al. Among authors: chen l. Biofactors. 2024 Jul-Aug;50(4):624-633. doi: 10.1002/biof.2032. Epub 2023 Dec 29. Biofactors. 2024. PMID: 38158592 Review.

10

Emerging role of Protein Kinase CK2 in Tumor immunity.

Chen L, Zhang S, Li Q, Li J, Deng H, Zhang S, Meng R. Chen L, et al. Front Oncol. 2022 Dec 1;12:1065027. doi: 10.3389/fonc.2022.1065027. eCollection 2022. Front Oncol. 2022. PMID: 36530985 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88,489 results

Search Page

Filters